SubsidieMeestersBreast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue
LATTICE MEDICAL's MATTISSE project aims to launch a fully degradable 3D printed breast implant for natural reconstruction, enhancing recovery and safety for women by 2030.
Projectdetails
Introduction
LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery.
Technology Overview
MATTISSE technology uses a Tissue Engineering Chamber implanted in the former breast and made of 3D printed biocompatible and bioabsorbable polymer.
Regeneration Process
MATTISSE regenerates autologous adipose tissue within 3-6 months. Women recover a full breast in 18 months with a fully degraded implant at an affordable price and free from numerous surgical procedures.
Safety Benefits
There is no longer any risk related to silicone implants thanks to the complete recovery with natural tissue.
Clinical Studies
After validating the effectiveness of the MATTISSE medical device on animal models, this project aims at performing the mandatory clinical studies to launch the product on the EU market with the CE mark.
Marketing Strategy
A commercial team will be recruited to define and implement a marketing plan to ensure the success of MATTISSE.
Future Goals
Lattice Medical plans to support 40,000 women by 2030.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.438.488 |
| Totale projectbegroting | € 3.483.555 |
Tijdlijn
| Startdatum | 1-10-2022 |
| Einddatum | 30-9-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- LATTICE MEDICALpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A natural breast for cancer survivors: resorbable implant supporting tissue regenerationREGENERA aims to provide lumpectomy patients with a resorbable implant that promotes natural breast restoration through tissue self-regeneration, minimizing pain and follow-up surgeries. | EIC Accelerator | € 2.498.600 | 2023 | Details |
A natural breast for cancer survivors: resorbable implant supporting tissue regeneration
REGENERA aims to provide lumpectomy patients with a resorbable implant that promotes natural breast restoration through tissue self-regeneration, minimizing pain and follow-up surgeries.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Dan Jing WuVivArt-X ontwikkelt een innovatief synthetisch biomateriaal voor veiligere en effectievere borstreconstructie na borstamputatie. | Mkb-innovati... | € 19.320 | 2023 | Details |
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restorationBIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness. | EIC Pathfinder | € 4.039.541 | 2022 | Details |
ArvinaArvina ontwikkelt een synthetisch biomateriaal voor effectieve borstreconstructie, ter verbetering van de levenskwaliteit van borstkankerpatiënten. | 1.1 - Het ve... | € 482.195 | 2023 | Details |
AIM+; De ontwikkeling van een poreus, titanium implantaat voor wervelfracturenHet project ontwikkelt een innovatief, 3D-geprint titanium implantaat voor wervelfracturen dat botgroei bevordert en complicaties van traditionele behandelingen vermindert. | Mkb-innovati... | € 162.175 | 2019 | Details |
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticlesThe NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release. | ERC Proof of... | € 150.000 | 2024 | Details |
Dan Jing Wu
VivArt-X ontwikkelt een innovatief synthetisch biomateriaal voor veiligere en effectievere borstreconstructie na borstamputatie.
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.
Arvina
Arvina ontwikkelt een synthetisch biomateriaal voor effectieve borstreconstructie, ter verbetering van de levenskwaliteit van borstkankerpatiënten.
AIM+; De ontwikkeling van een poreus, titanium implantaat voor wervelfracturen
Het project ontwikkelt een innovatief, 3D-geprint titanium implantaat voor wervelfracturen dat botgroei bevordert en complicaties van traditionele behandelingen vermindert.
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.